These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11042692

  • 1. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
    Vannucchi S, Percario ZA, Chiantore MV, Matarrese P, Chelbi-Alix MK, Fagioli M, Pelicci PG, Malorni W, Fiorucci G, Romeo G, Affabris E.
    Oncogene; 2000 Oct 19; 19(44):5041-53. PubMed ID: 11042692
    [Abstract] [Full Text] [Related]

  • 2. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
    Lancillotti F, Giandomenico V, Affabris E, Fiorucci G, Romeo G, Rossi GB.
    Cancer Res; 1995 Jul 15; 55(14):3158-64. PubMed ID: 7606736
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
    Giandomenico V, Vaccari G, Fiorucci G, Percario Z, Vannuchi S, Matarrese P, Malorni W, Romeo G, Affabris GR.
    Eur Cytokine Netw; 1998 Dec 15; 9(4):619-31. PubMed ID: 9889406
    [Abstract] [Full Text] [Related]

  • 4. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
    Son SH, Yu E, Choi EK, Lee H, Choi J.
    Cancer Gene Ther; 2005 Jan 15; 12(1):1-11. PubMed ID: 15529177
    [Abstract] [Full Text] [Related]

  • 5. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
    Giannini F, Maestro R, Vukosavljevic T, Pomponi F, Boiocchi M.
    Int J Cancer; 1997 Jan 17; 70(2):194-200. PubMed ID: 9009160
    [Abstract] [Full Text] [Related]

  • 6. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
    Flinterman M, Gäken J, Farzaneh F, Tavassoli M.
    Oncogene; 2003 Apr 03; 22(13):1965-77. PubMed ID: 12673202
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
    Um SJ, Kim EJ, Hwang ES, Kim SJ, Namkoong SE, Park JS.
    Int J Cancer; 2000 Feb 01; 85(3):416-23. PubMed ID: 10652435
    [Abstract] [Full Text] [Related]

  • 8. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG.
    Cancer Res; 1994 Aug 15; 54(16):4508-15. PubMed ID: 7519122
    [Abstract] [Full Text] [Related]

  • 9. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
    Giandomenico V, Lancillotti F, Fiorucci G, Percario ZA, Rivabene R, Malorni W, Affabris E, Romeo G.
    Cell Growth Differ; 1997 Jan 15; 8(1):91-100. PubMed ID: 8993838
    [Abstract] [Full Text] [Related]

  • 10. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.
    Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
    Yokoyama M, Nakao Y, Iwasaka T, Pater A, Sugimori H.
    Obstet Gynecol; 2001 Aug 15; 98(2):332-40. PubMed ID: 11506854
    [Abstract] [Full Text] [Related]

  • 13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP.
    Nat Genet; 1999 Nov 15; 23(3):287-95. PubMed ID: 10610177
    [Abstract] [Full Text] [Related]

  • 14. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
    Massad LS, Turyk ME, Bitterman P, Wilbanks GD.
    Gynecol Oncol; 1996 Mar 15; 60(3):428-34. PubMed ID: 8774652
    [Abstract] [Full Text] [Related]

  • 15. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP.
    Nat Genet; 1998 Feb 15; 18(2):126-35. PubMed ID: 9462740
    [Abstract] [Full Text] [Related]

  • 16. The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 beta, a cytokine that directly inhibits growth of lung cancer cells.
    Ross HJ.
    Oncol Res; 1996 Feb 15; 8(4):171-8. PubMed ID: 8869967
    [Abstract] [Full Text] [Related]

  • 17. All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1.
    Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ.
    Exp Cell Res; 1997 May 01; 232(2):277-86. PubMed ID: 9168803
    [Abstract] [Full Text] [Related]

  • 18. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.
    Yu JH, Nakajima A, Nakajima H, Diller LR, Bloch KD, Bloch DB.
    Cancer Res; 2004 Feb 01; 64(3):928-33. PubMed ID: 14871822
    [Abstract] [Full Text] [Related]

  • 19. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
    Le XF, Vallian S, Mu ZM, Hung MC, Chang KS.
    Oncogene; 1998 Apr 09; 16(14):1839-49. PubMed ID: 9583681
    [Abstract] [Full Text] [Related]

  • 20. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E.
    Differentiation; 1997 Aug 09; 61(5):321-31. PubMed ID: 9342843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.